Literature DB >> 32815150

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.

Helén Nilsson1, David Lindgren2, Håkan Axelson2, Christian Brueffer3, Lao H Saal3, Jaana Lundgren4, Martin E Johansson4,5,6.   

Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common form of renal cancer. Due to inactivation of the von Hippel-Lindau tumour suppressor, the hypoxia-inducible transcription factors (HIFs) are constitutively activated in these tumours, resulting in a pseudo-hypoxic phenotype. The HIFs induce the expression of genes involved in angiogenesis and cell survival, but they also reset the cellular metabolism to protect cells from oxygen and nutrient deprivation. ccRCC tumours are highly vascularized and the cytoplasm of the cancer cells is filled with lipid droplets and glycogen, resulting in the histologically distinctive pale (clear) cytoplasm. Intratumoural heterogeneity may occur, and in some tumours, areas with granular, eosinophilic cytoplasm are found. Little is known regarding these traits and how they relate to the coexistent clear cell component, yet eosinophilic ccRCC is associated with higher grade and clinically more aggressive tumours. In this study, we have for the first time performed RNA sequencing comparing histologically verified clear cell and eosinophilic areas from ccRCC tissue, aiming to analyse the characteristics of these cell types. Findings from RNA sequencing were confirmed by immunohistochemical staining of biphasic ccRCC. We found that the eosinophilic phenotype displayed a higher proliferative drive and lower differentiation, and we confirmed a correlation to tumours of higher stage. We further identified mutations of the tumour suppressor p53 (TP53) exclusively in the eosinophilic ccRCC component, where mTORC1 activity was also elevated. Also, eosinophilic areas were less vascularized, yet harboured more abundant infiltrating immune cells. The cytoplasm of clear cell ccRCC cells was filled with lipids but had very low mitochondrial content, while the reverse was found in eosinophilic tissue. We herein suggest possible transcriptional mechanisms behind these phenomena.
© 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland.

Entities:  

Keywords:  VHL; clear cell; electron microscopy; eosinophilic; granular; kidney cancer; mTOR; mitochondria; p53; renal cell carcinoma; vasculature

Year:  2020        PMID: 32815150      PMCID: PMC7756750          DOI: 10.1002/path.5532

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  66 in total

1.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.

Authors:  Christopher J Ricketts; Aguirre A De Cubas; Huihui Fan; Christof C Smith; Martin Lang; Ed Reznik; Reanne Bowlby; Ewan A Gibb; Rehan Akbani; Rameen Beroukhim; Donald P Bottaro; Toni K Choueiri; Richard A Gibbs; Andrew K Godwin; Scott Haake; A Ari Hakimi; Elizabeth P Henske; James J Hsieh; Thai H Ho; Rupa S Kanchi; Bhavani Krishnan; David J Kwiatkowski; Wembin Lui; Maria J Merino; Gordon B Mills; Jerome Myers; Michael L Nickerson; Victor E Reuter; Laura S Schmidt; C Simon Shelley; Hui Shen; Brian Shuch; Sabina Signoretti; Ramaprasad Srinivasan; Pheroze Tamboli; George Thomas; Benjamin G Vincent; Cathy D Vocke; David A Wheeler; Lixing Yang; William Y Kim; A Gordon Robertson; Paul T Spellman; W Kimryn Rathmell; W Marston Linehan
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

Review 2.  The role of mutant p53 in human cancer.

Authors:  Amanda M Goh; Cynthia R Coffill; David P Lane
Journal:  J Pathol       Date:  2010-10-25       Impact factor: 7.996

3.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.

Authors:  Christian M Metallo; Paulo A Gameiro; Eric L Bell; Katherine R Mattaini; Juanjuan Yang; Karsten Hiller; Christopher M Jewell; Zachary R Johnson; Darrell J Irvine; Leonard Guarente; Joanne K Kelleher; Matthew G Vander Heiden; Othon Iliopoulos; Gregory Stephanopoulos
Journal:  Nature       Date:  2011-11-20       Impact factor: 49.962

4.  Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes.

Authors:  David Lindgren; Pontus Eriksson; Krzysztof Krawczyk; Helén Nilsson; Jennifer Hansson; Srinivas Veerla; Jonas Sjölund; Mattias Höglund; Martin E Johansson; Håkan Axelson
Journal:  Cell Rep       Date:  2017-08-08       Impact factor: 9.423

5.  A mitochondrial protein compendium elucidates complex I disease biology.

Authors:  David J Pagliarini; Sarah E Calvo; Betty Chang; Sunil A Sheth; Scott B Vafai; Shao-En Ong; Geoffrey A Walford; Canny Sugiana; Avihu Boneh; William K Chen; David E Hill; Marc Vidal; James G Evans; David R Thorburn; Steven A Carr; Vamsi K Mootha
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

Review 6.  The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.

Authors:  Zbyslaw Sondka; Sally Bamford; Charlotte G Cole; Sari A Ward; Ian Dunham; Simon A Forbes
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

7.  mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.

Authors:  Steffen Rausch; Daniel Schollenberger; Joerg Hennenlotter; Viktoria Stühler; Stephan Kruck; Arnulf Stenzl; Jens Bedke
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-27       Impact factor: 4.553

8.  Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift.

Authors:  Pablo Cingolani; Viral M Patel; Melissa Coon; Tung Nguyen; Susan J Land; Douglas M Ruden; Xiangyi Lu
Journal:  Front Genet       Date:  2012-03-15       Impact factor: 4.599

9.  RADAR: a rigorously annotated database of A-to-I RNA editing.

Authors:  Gokul Ramaswami; Jin Billy Li
Journal:  Nucleic Acids Res       Date:  2013-10-25       Impact factor: 16.971

10.  VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.

Authors:  Zhongwu Lai; Aleksandra Markovets; Miika Ahdesmaki; Brad Chapman; Oliver Hofmann; Robert McEwen; Justin Johnson; Brian Dougherty; J Carl Barrett; Jonathan R Dry
Journal:  Nucleic Acids Res       Date:  2016-04-07       Impact factor: 16.971

View more
  5 in total

1.  Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.

Authors:  Chisato Ohe; Takashi Yoshida; Mahul B Amin; Naho Atsumi; Junichi Ikeda; Kazuho Saiga; Yuri Noda; Yoshiki Yasukochi; Riuko Ohashi; Haruyuki Ohsugi; Koichiro Higasa; Hidefumi Kinoshita; Koji Tsuta
Journal:  Mod Pathol       Date:  2021-11-30       Impact factor: 7.842

2.  Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma.

Authors:  Yusa Chen; Yumei Liang; Ying Chen; Shaxi Ouyang; Kanghan Liu; Wei Yin
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375

3.  Predicting Clear Cell Renal Cell Carcinoma Survival Using Kurtosis of Cytoplasm in the Hematoxylin Channel from Histology Slides.

Authors:  Jun Wang; Jianhui Chen; Liren Jiang; Qi Wu; Dawei Wang
Journal:  J Oncol       Date:  2022-01-13       Impact factor: 4.375

4.  Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade.

Authors:  Takashi Yoshida; Chisato Ohe; Junichi Ikeda; Naho Atsumi; Haruyuki Ohsugi; Motohiko Sugi; Koichiro Higasa; Ryoichi Saito; Koji Tsuta; Tadashi Matsuda; Hidefumi Kinoshita
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 13.751

5.  Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.

Authors:  Takashi Yoshida; Chisato Ohe; Junichi Ikeda; Naho Atsumi; Ryoichi Saito; Hisanori Taniguchi; Haruyuki Ohsugi; Motohiko Sugi; Koji Tsuta; Tadashi Matsuda; Hidefumi Kinoshita
Journal:  J Pathol Clin Res       Date:  2021-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.